Skip to main
BLCO
BLCO logo

BLCO Stock Forecast & Price Target

BLCO Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 13%
Buy 27%
Hold 53%
Sell 7%
Strong Sell 0%

Bulls say

Bausch & Lomb has demonstrated robust growth across its segments, with contact lens market share increasing by 40 basis points year-over-year to 10% and surgical revenues reaching $231 million, representing a 13% increase year-over-year. The ophthalmic pharmaceuticals segment also showed positive momentum, with revenues of $326 million growing by approximately 6% year-over-year, in spite of foreign exchange headwinds, while consumer segment revenues climbed to $476 million, up 8% year-over-year, exceeding analyst expectations. Additionally, the notable strength in premium intraocular lenses, which saw a 67% year-over-year increase, highlights Bausch & Lomb’s diverse and expanding product portfolio, further reinforcing a favorable outlook for the company.

Bears say

Bausch & Lomb is facing a negative outlook primarily due to projected flat to low-single digit revenue growth, which is expected to impede operating margin improvement and earnings per share (EPS) growth. The company is contending with multiple operational risks, including competitive pressures from lower-cost online contact lens providers, potential disruptions from ongoing geopolitical conflicts, and challenges in executing commercial launches. Additionally, revisions to EPS forecasts indicate a decline, with estimates for 2025 and 2026 reduced significantly, highlighting concerns over its market positioning amid lower margins in certain segments and high leverage.

BLCO has been analyzed by 15 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 27% recommend Buy, 53% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bausch + Lomb Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bausch + Lomb Corp (BLCO) Forecast

Analysts have given BLCO a Hold based on their latest research and market trends.

According to 15 analysts, BLCO has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bausch + Lomb Corp (BLCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.